Skip to main content
Premium Trial:

Request an Annual Quote

Wait, This Is Satire?

If you've already read and re-read Richard Russo's Straight Man so many times that the book's binding has come undone, you might want to give a new novel from Daniel Greenberg called Tech Transfer a try. The New York Times' Nicholas Wade calls it "a mordant satire about scientists and universities and how they do business." In the novel, the trustees of a university select a new president who "learns the folly of challenging the tenured faculty on any of their sacrosanct, non-negotiable issues," Wade says, and those untouchable issues include just about everything: pay raises every year, lenient conflict-of-interest rules, and indulgent disciplinary procedures.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.